(Q43946490)

English

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

0 references

diabetic macular edema

1 reference

based on heuristic

inferred from title

author name string

Hideharu Funatsu

1

1 reference

Europe PubMed Central

28 November 2017

Hidetoshi Yamashita

2

1 reference

Europe PubMed Central

28 November 2017

Tomohiro Ikeda

3

1 reference

Europe PubMed Central

28 November 2017

Yuichiro Nakanishi

4

1 reference

Europe PubMed Central

28 November 2017

Shigehiko Kitano

5

1 reference

Europe PubMed Central

28 November 2017

Sadao Hori

6

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

28 November 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

28 November 2017

133

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

537-543

1 reference

Europe PubMed Central

28 November 2017

The 14-year incidence of visual loss in a diabetic population.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Diabetic macular edema. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Serum angiotensin converting enzyme in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Localization of vascular endothelial growth factor in human retina and choroid

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

New surgical approach for removing massive foveal hard exudates in diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

The role of the vitreous in diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901323-5

7 January 2021

Identifiers

10.1016/S0002-9394(02)01323-5

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43946490&oldid=2104572520"